LifeMD, Inc. reported significant financial performance improvements in its latest 10-Q filing for the quarter ending June 30, 2025. The company generated total revenues of $62.2 million, marking a 23% increase from $50.7 million in the same period last year. This growth was primarily driven by a 30% rise in telehealth revenue, which reached $48.6 million, up from $37.4 million. The company's WorkSimpli segment also contributed, with revenues increasing by 3% to $13.7 million. Despite the revenue growth, LifeMD recorded a net loss of $2.1 million for the quarter, an improvement from a net loss of $6.9 million in the prior year.
In terms of operational metrics, LifeMD reported approximately 297,000 active patient subscribers, reflecting the company's expanding reach in the telehealth market. The company has also seen a notable increase in its telehealth subscription revenue, which accounted for 94% of total telehealth revenue. The company’s gross profit for the quarter was $54.8 million, representing 88% of total revenues, although this was a slight decrease from 90% in the previous year, attributed to rising shipping and physician consult fees.
Strategically, LifeMD has made significant moves, including the acquisition of OHHMD, a virtual care provider focused on women's health, which positions the company to expand its offerings in this market. The acquisition was completed in April 2025 and is expected to enhance LifeMD's service capabilities. Additionally, the company has launched new programs, such as the GLP-1 Weight Management Program, which has rapidly grown to approximately 84,000 patient subscribers.
Financially, LifeMD's total assets increased to $73.6 million as of June 30, 2025, compared to $72.5 million at the end of 2024. However, the company reported a working capital deficit of $14.5 million, up from $11.5 million at the end of the previous fiscal year. The increase in current liabilities was primarily due to a rise in accounts payable and accrued expenses. Looking ahead, LifeMD anticipates continued revenue growth and operational improvements, supported by its strategic initiatives and a strong cash position of $36.2 million as of June 30, 2025. The company remains focused on enhancing its telehealth services and expanding its market presence.
About LifeMD, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.